KateBramham United KingdomKing's College London

KateBramham
Dr Kate Bramham is passionate about addressing health inequalities and is committed to changing the trajectory of kidney disease and cardiovascular health, particularly in Black communities, for women and those with mental health difficulties. She has authored >150 original manuscripts and book chapters on renal disease, ethnicity and pregnancy and has contributed to national and international guidelines. Her work focuses on improving the detection and prevention of early kidney disease through community-led, point-of-care, and digital inclusion approaches, and developing novel treatments to protect kidney function in people of African ancestry and during pregnancy. She is the Chief Investigator for several multi-centre NIHR, UKRI and charity funded studies and holds >£12m grant funding addressing health inequalities in the UK and Africa.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/66423695b4099bfd3c950f8c86257ec7.jpg
First name
Kate
Last name
Bramham
Institution
Country
United Kingdom

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
Navigating Pregnancy and Kidney Disease: Risks, Benefits, and Global Insights. ISN-WIN/WIN India Joint Session
LF2004
LizLightstone Chair United KingdomImperial College London
RashaDarwish Chair EgyptKasr Aleiny medical school , Cairo University
UrmilaAnandh Chair IndiaAmrita Hospitals, Faridabad, Delhi NCR
  • Patient Presentation
    LF2004-01
  • Pregnancy-related AKI – a Lethal Problem
    LF2004-02
    DIVYABAJPAI Speaker IndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India
  • aHUS in Pregnancy - What Do We Know and What Can We Do?
    LF2004-03
    AnujaJava Speaker United StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS
  • Using Pregnancy to Initiate Long-term Kidney Care for Women
    LF2004-04
    SaraladeviNaicker Speaker South AfricaUniversity of the Witwatersrand
  • Developmental Origins of Kidney Disease: It’s All About Mother
    LF2004-05
    KateBramham Speaker United KingdomKing's College London
  • Panel Discussion with Speakers: How to Change Things? How to Raise Awareness?
    LF2004-06
Gulmohar Hall 302

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
HIT! High Impact Clinical Trials – Why and How
HIT2
DavidWheeler Chair United KingdomUniversity College London
Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong
  • What Have We Learned From CONVINCE?
    HIT2-1
    PeterBlankestijn Oral Abstract Presenter NetherlandsUniversity Medical Center Utrecht
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    HIT2-2
    VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    HIT2-3
    JonathanBarratt Oral Abstract Presenter United KingdomUniversity of Leicester, Leicester, UK
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    HIT2-4
    KateBramham Oral Abstract Presenter United KingdomKing's College London
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    HIT2-5
    Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India
    SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore
Brahmkamal Hall - Plenary Hall